Physician profile
David M Mueller
NPI 1689874745
$803.23
in general payments reported to CMS, 2019-2025
18 companies · $221 in 2025
The $221 reported for 2025 was more than what 77% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.42 · 2020: $36.86 · 2021: $51.27 · 2022: $71.77 · 2023: $146 · 2024: $178 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $195.87 | 2023-2025 | |
| Glaxosmithkline, LLC. | $121.94 | 2019-2025 | Bexsero, Menveo, Rotarix |
| Supernus Pharmaceuticals, INC. | $96.80 | 2021-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $90.66 | 2022-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Biomarin Pharmaceutical INC. | $40.52 | 2024-2025 | Voxzogo 1.2mg |
| Ultragenyx Pharmaceutical INC. | $30.76 | 2019-2022 | |
| Sanofi Pasteur INC. | $27.53 | 2021-2024 | |
| Sobi, INC | $27.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.87 | 2024 | |
| Mallinckrodt Hospital Products INC. | $22.94 | 2020 | |
| Seqirus USA INC | $21.09 | 2025 | Flucelvax |
| Corium, LLC | $21.08 | 2023 | Azstarys |
| Collegium Pharmaceutical, INC. | $15.18 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $14.49 | 2019 | |
| Nestle Healthcare Nutrition INC. | $14.33 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.43 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $13.34 | 2022 | |
| Medtronic USA, INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.